Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein

Experimental Hematology

Volumn 29, Issue 9, 2001, Pages 1082-1090

  Ergin, M ^a   Denning, M F ^a   Izban, K F ^a   Amin, H M ^a   Martinez, R L ^a   Saeed, S ^a   Alkan, S ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CASPASE; HERBIMYCIN A; IMATINIB; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL VIABILITY; ENZYME INHIBITION; GENE TRANSLOCATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; STAINING; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOQUINONES; CASPASES; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; ENZYME INHIBITORS; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LACTAMS, MACROCYCLIC; LYMPHOMA, LARGE-CELL; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; QUINONES; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034888811     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00688-9     Document Type: Article

References (41)

1. Primary anaplastic large-cell lymphoma in adults; clinical presentation, immunophenotype, and outcome
2. Fusion of a kinase gene ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
3. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma')
4. + anaplastic large cell lymphoma
5. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma associated NPM-anaplastic lymphoma kinase fusion protein in oncogen
6. Major nucleolar proteins shuttle between nucleus and cytoplasm
7. + large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35
8. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM) ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
9. Atic-alk; A novel variant alk gene fusion in anaplastic large cell lymphoma from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)
10. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma with a (1;2)(q25;p23) translocation
11. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis
12. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma
13. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma
14. Characterization of PDGF tyrosine kinase inhibitors in in vitro and in vivo tumors
15. Inhibitors of tyrosine kinase
16. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
17. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
18. Clinical efficacy and safety of an abl specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia
19. Protein tyrosine kinases and cancer
20. Nucleophosmin-anaplastic lymphoma kinase of large cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase c-γ to mediate its mitogenicity
21. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)
22. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
23. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice
24. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene upregulation in rat 1a fibroblasts
25. Lymphoma classification-from controversy to consensus; the R.E.A.L. and WHO classification of lymphoid neoplasms
26. Monoclonal antibodies to phosphotyrosine
27. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements
28. Immunohistochemical screening for oncogenic tyrosine kinase activation
29. Characterization of the interleukin-1 β-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease; lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease
30. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
31. Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148
32. + cells
33. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro
34. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
35. Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases
36. + cells
37. Life and death decisions; regulation of apoptosis by proteolysis signaling molecules
38. BCL-2 family members and the mitochondria in apoptosis
39. + leukemia cells
40. Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase
41. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway